Biswas Bijit, Pathak Hem Nandani, Gupta Pratima, Jahnavi G, Kalyani C Vasantha, Varshney Saurabh
Community and Family Medicine, All India Institute of Medical Sciences, Deoghar, IND.
Microbiology, All India Institute of Medical Sciences, Deoghar, IND.
Cureus. 2025 Jun 8;17(6):e85552. doi: 10.7759/cureus.85552. eCollection 2025 Jun.
Undergraduate healthcare students are future frontline communicators in India's effort to eliminate lymphatic filariasis (LF) through mass drug administration (MDA). This study assessed their perception and practices regarding LF and MDA in an endemic tertiary care setting in Eastern India.
A cross-sectional survey was conducted in April 2024 among 465 medical and nursing undergraduates using a 39-item self-administered questionnaire. Knowledge scores were calculated for LF (0-20), MDA (0-19), and total (0-39). Data on MDA compliance, drug intake practices, and adverse reactions were also collected.
The mean total knowledge score was 21.2 ± 5.9, with LF and MDA scores of 8.9 ± 3.4 and 12.2 ± 3.7, respectively. Only 37.6% correctly identified 2027 as India's LF elimination target, and 34.8% were aware of the recommended triple-drug regimen. Although 85.6% reported MDA intake, 25.4% did not follow correct consumption protocols. Among those who took drugs on an empty stomach, 46.9% reported adverse drug reactions versus 26.0% of others (p < 0.001); nausea (39.3%) and headache (29.9%) were most common. Knowledge scores were significantly higher among older students (≥24 years: 24.0 ± 5.5 vs. 18-19 years: 19.5 ± 5.5; p < 0.001), medical stream (21.8 ± 6.0 vs. 18.9 ± 5.2; p < 0.001), and consistent MDA participants (23.7 ± 4.9 vs. 12.5 ± 3.9; p < 0.001).
Despite high MDA coverage, significant gaps exist in knowledge and appropriate drug use. Targeted training and curricular integration are essential to strengthen undergraduate engagement in LF elimination.
在印度通过大规模药物给药(MDA)消除淋巴丝虫病(LF)的努力中,本科医学生是未来的一线沟通者。本研究评估了印度东部一所地方三级医疗环境中他们对LF和MDA的认知及实践情况。
2024年4月,使用一份39项的自填问卷对465名医科和护理专业本科生进行了横断面调查。计算LF(0 - 20分)、MDA(0 - 19分)和总分(0 - 39分)的知识得分。还收集了关于MDA依从性、药物服用实践和不良反应的数据。
平均总知识得分为21.2±5.9,LF和MDA得分分别为8.9±3.4和12.2±3.7。只有37.6%的人正确将2027年确定为印度的LF消除目标,34.8%的人知晓推荐的三联药物疗法。尽管85.6%的人报告服用了MDA,但25.4%的人未遵循正确的服用方案。在空腹服药的人群中,46.9%的人报告有药物不良反应,而其他人群为26.0%(p<0.001);恶心(39.3%)和头痛(29.9%)最为常见。年龄较大的学生(≥24岁:24.0±5.5 vs. 18 - 19岁:19.5±5.5;p<0.001)、医学专业(21.8±6.0 vs. 18.9±5.2;p<0.001)以及持续参与MDA的参与者(23.7±4.9 vs. 12.5±3.9;p<0.001)的知识得分显著更高。
尽管MDA覆盖率较高,但在知识和合理用药方面仍存在显著差距。有针对性的培训和课程整合对于加强本科学生参与LF消除工作至关重要。